Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2
Holding GB:0HD2?
Track your performance easily
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 659.83M | $ 494.33M | $ 439.72M | $ 750.53M | $ 305.70M |
| Gross Profit | $ 592.55M | $ 439.72M | $ 353.86M | $ 671.06M | $ 253.45M |
| EBIT | $ -11.17M | $ -16.97M | $ -106.35M | $ 181.63M | $ -244.17M |
| EBITDA | $ -1.48M | $ -5.00M | $ -82.38M | $ 191.84M | $ -233.91M |
| Net Income Common Stockholders | $ -16.89M | $ -65.94M | $ -137.87M | $ 157.43M | $ -276.02M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 2.62B | $ 2.37B | $ 2.44B | $ 2.41B | $ 2.06B |
| Total Assets | $ 4.01B | $ 3.82B | $ 3.83B | $ 3.84B | $ 3.40B |
| Total Debt | $ 1.30B | $ 1.30B | $ 1.31B | $ 1.31B | $ 1.31B |
| Net Debt | $ -1.32B | $ -1.07B | $ -1.13B | $ -1.10B | $ -743.17M |
| Total Liabilities | $ 4.01B | $ 4.04B | $ 4.05B | $ 4.00B | $ 3.81B |
| Stockholders Equity | $ -3.07M | $ -219.27M | $ -220.64M | $ -165.87M | $ -408.13M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 116.14M | $ -94.49M | $ -45.10M | $ 342.32M | $ -74.91M |
| Operating Cash Flow | $ 124.16M | $ -81.52M | $ -29.80M | $ 359.41M | $ -58.99M |
| Investing Cash Flow | $ 33.94M | $ -67.62M | $ -240.66M | $ -10.76M | $ -8.71M |
| Financing Cash Flow | $ 131.50M | $ 28.91M | $ 39.23M | $ 33.14M | $ 53.39M |